Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

May 15 2000
WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150...
May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine...
May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s...
May 1 2000
A Position Paper fromThe Biotechnology Industry Organization Executive Summary 1. Human organ transplantation faces a significant challenge because the need...
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton...
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to...
Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...
Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who...
Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued...